Safdarjung Hospital removes world's largest adrenal tumour via robotic surgery
In a landmark surgical feat, doctors at Safdarjung Hospital have successfully removed what is being claimed as the world's largest adrenal tumour ever extracted using robotic technology. The tumour, measuring 18.2 x 13.5 cm, was removed from a 36-year-old woman through a complex, minimally invasive procedure.
'This is the largest ever adrenal tumour in the world to have been removed robotically in a minimally invasive fashion,' Dr. Sandeep Bansal, Medical Superintendent of Safdarjung Hospital, said on Saturday (April 26, 2025).
The tumour posed significant challenges due to its size and the fact that it was adherent to three critical anatomical structures - the Inferior Vena Cava, liver, and right kidney. 'Its proximity and adherence to vital organs made the surgery particularly intricate,' the surgical team said.
The procedure was performed using the Da Vinci surgical robot, which provides a three-dimensional view and enhanced precision through its advanced robotic arms. 'The technology allows for greater control and accuracy, especially in areas where conventional laparoscopic access is limited,' doctors explained.
The surgery lasted over three hours, and the tumour was removed without any complications. The patient had an uneventful recovery and was discharged three days after the operation.
Doctors highlighted the advantages of robotic surgery, which include smaller incisions, reduced post-operative pain, faster recovery, and quicker return to normal activities. By contrast, an open procedure for a tumour of this size would have required an incision of over 20 cm and significantly longer recovery time.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
30-05-2025
- Hans India
Robotic-assisted surgery steadily transforming gynaecological care: Study
Bengaluru: A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. 'Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women,' said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. 'Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases,' said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. 'We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss,' said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. 'It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work,' added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. 'Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision,' explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. 'Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases,' he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. 'Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options,' Dr Saha added.
&w=3840&q=100)
Business Standard
29-05-2025
- Business Standard
Robotic-assisted surgery steadily transforming gynaecological care: study
A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. "Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women," said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. "Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases," said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. "We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss," said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. "It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work," added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. "Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision," explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. "Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases," he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. "Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options," Dr Saha added. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Mint
26-05-2025
- Mint
Mint Primer: Dr AI is here, but will the human touch go away?
Shanghai-based company Synyi AI recently unveiled a fully artificial intelligence (AI)-run clinic in Saudi Arabia. While AI excels at diagnosis, it lacks human empathy and nuanced judgement. Is the future of healthcare hybrid or autonomous? And can we trust AI docs? Just how do these AI clinics function? Synyi AI works with hospitals in China, using AI for diagnosis and medical research. Its new clinic, built with Saudi Arabia's Almoosa Health Group as a pilot, is led by an AI 'doctor". Christened Dr Hua, it independently conducts consultations, diagnoses, and suggests treatments via a tablet. A human doctor then reviews and approves each plan. This marks a shift from AI as a support tool to primary care providers. The AI doctor covers about 30 respiratory illnesses, including asthma and pharyngitis. Synyi plans to expand its scope to 50 conditions including gastrointestinal and dermatological problems. Read more: Mint Primer: A robot for every 3 humans: What happens to us? From assistant to doc seems like a jump... Not really. AI systems already assist with checking symptoms, asking routine questions, and prioritizing patients before doctors take over. They can interpret scans and flag critical results. Hospitals in South Korea, China, India and the UAE use AI to manage logistics, bed-use and infection control. In May 2024, Tsinghua University went a step further when it introduced a virtual 'Agent Hospital" with large language model (LLM)-powered doctors. Months later, Bauhinia Zhikang launched 42 AI doctors across 21 departments for internal testing of their diagnostics. With Synyi AI, fully autonomous clinics may become commonplace. What can AI doctors do that humans can't? AI tools from Google, Microsoft, Meta, Amazon and Nvidia can analyze X-rays, medical records and large datasets with precision and speed. They also generate treatment summaries. Unlike humans, AI doctors don't get tired. They can handle up to 10,000 patients a week, compared with around 100 by a typical human doctor—valuable in overburdened health systems. Can AI replace human doctors entirely? AI excels at repetitive, data-heavy tasks like diagnosing common illnesses, analyzing scans and flagging abnormalities. Surgical robots like Da Vinci are used in hospitals worldwide, including Apollo, AIIMS and Fortis in India. But AI lacks empathy, moral reasoning, and adaptability in complex or unclear cases. Even at Synyi's AI-run clinic, a human doctor must approve each decision. Over-promising, too, can be risky. Babylon Health collapsed after its claims of diagnosing better than doctors fell short. Read more: AI application startups in India set to get more investments from VC firms Accel, Peak XV, Lightspeed Can AI in healthcare be trusted? There is a need for supervision given growing use in Asia—from surgical robots in South Korea, China, Japan and India to home-care AI research in Singapore. But regulation is catching up: Europe's AI Act, the US FDA and the World Health Organisation (WHO) all emphasize transparency, safety, and ethics, especially as LLMs can hallucinate (provide false answers confidently) and show bias. India's medical ethics code requires doctors to disclose AI use to patients. Keeping human doctors in the loop remains key for trust.
